Welcome to the Sleepy Brain Lab!
The Sleepy Brain Laboratory leverages sleep and circadian
markers towards novel interventions and elucidation of
- Probe the relationships between postoperative delirium and perioperative sleep and circadian markers.
- Evaluate novel interventions for modulating the interface between human anesthesia and/sleep states and impact on downstream cognition and behavior.
- Evaluate the role of sleep in rapid-acting interventions for treatment-resistant depression.
- Quantitative EEG
- Sleep recordings with wireless wearable devices
- Resting-state functional magnetic resonance imaging
- Translational interventions involving sedation and general anesthesia
The Sleepy Brain Lab is made up of clever, skilled, and thoughtful researchers, doctors, and students. Each member of our Lab brings a unique perspective to our work and provides invaluable insight to our research projects.
Dr. Kafashan Received a 5-year K01 Award from the National Institute of Mental Health to Study “Disruptions of Brain Networks and Sleep by Electroconvulsive Therapy”
Mehdi Kafashan, PhD, MSc, Instructor of Anesthesiology at Washington University School of Medicine in St. Louis, has received a 5-year $793,965 K01 grant from the National Institute of Mental Health (NIMH) to study “Disruptions of Brain Networks and Sleep by Electroconvulsive Therapy (DNS-ECT)”.
Dr. Smith scheduled to present at 2022 ASA Annual Meeting
Dr. Kendall Smith is scheduled to present at the American Society of Anesthesiologists Annual Meeting on October 21-25 in New Orleans at the Ernest N. Morial Convention Center.
Dr. Palanca scheduled to speak at Stanford University
Dr. Ben Palanca is scheduled to speak at Stanford University on May 5, 2023.
Rachel and Kaitlyn scheduled to present at 2022 ASA Meeting
Rachel and Kaitlyn scheduled to present at 2022 ASA Meeting.
SWIPED trial will leverage propofol to probe relationships of slow-wave sleep, depression, and cognitive dysfunction
Drs. Palanca and Lenze have received a $703,237 grant from the National Institute of Mental Health (NIMH) to begin the Slow Wave Induction by Propofol to Eliminate Depression (SWIPED) clinical trial.